A Search Service for Abbreviation / Long Form

■ Abbreviation / Long Form : GS / Gleason sum

[Related PubMed/MEDLINE]
Total Number of Papers: 22
[Entries Per Page]
 per page
Page Control
Page: of
Abbreviation:   GS  (>> Co-occurring Abbreviation)
Long Form:   Gleason sum
 Abbreviation Variation
 Long Form Variation
 Pair(Abbreviation/Long Form) Variation
No. Year Title Co-occurring Abbreviation
2018 Pathologic Outcomes of Candidates for Active Surveillance Undergoing Radical Prostatectomy: Results from a Contemporary Turkish Patient Cohort. AS, PCa, PSA, RP
2017 Impact of treatment on progression to castration-resistance, metastases, and death in men with localized high-grade prostate cancer. ADT, CRPC, GLA-VA, HGPC, PCSM, RP
2017 Tumor Volume and Clinical Failure in High-Risk Prostate Cancer Patients Treated With Radical Prostatectomy. AUC, CF, hPCa, MVA, pT, RP, TV
2016 Feasibility for active surveillance in biopsy Gleason 3+4 prostate cancer: an Australian radical prostatectomy cohort. BCR, RP
2015 Agent Orange and long-term outcomes after radical prostatectomy. AO, BCR, PC
2015 Association between tumor-associated macrophages and microvessel density on prostate cancer progression. HGPIN, MVD, PCa, PSA, TAMs, TURP, vWF
2015 Diagnostic prostate biopsy performed in a non-academic center increases the risk of re-classification at confirmatory biopsy for men considering active surveillance for prostate cancer. AS, CI, OR
2015 Improving the prediction of pathologic outcomes in patients undergoing radical prostatectomy: the value of prostate cancer antigen 3 (PCA3), prostate health index (phi) and sarcosine. AS, AUC, DCA, PCa, PCA3, PHI, ROC, RP, TV
2015 Perineural invasion in prostate biopsy specimens is associated with increased bone metastasis in prostate cancer. PCa, PNI, tPSA, WBBS
10  2014 5alpha-Reductase inhibitors and risk of high-grade or lethal prostate cancer. 5ARIs, HR
11  2014 Concordance between transrectal ultrasound guided biopsy results and radical prostatectomy final pathology: Are we getting better at predicting final pathology? ---
12  2014 Correlation of Sprouty1 and Jagged1 with aggressive prostate cancer cells with different sensitivities to androgen deprivation. JAG1, Spry1
13  2013 Pathological outcome and biochemical recurrence-free survival after radical prostatectomy in African-American, Afro-Caribbean (Jamaican) and Caucasian-American men: an international comparison. AA, AC, BCR, CA, OC, RP
14  2012 Clinically significant Gleason sum upgrade: external validation and head-to-head comparison of the existing nomograms. AUC-ROC, DCA, LRPC, RP
15  2012 [Radiotherapy with androgen deprivation in high-risk prostate cancer: what outcomes on a Caribbean population?]. AD, PCa
16  2010 A nomogram for predicting upgrading in patients with low- and intermediate-grade prostate cancer in the era of extended prostate sampling. PSA, RP
17  2010 Can we predict real T3 stage prostate cancer in patients with clinical T3 (cT3) disease before radical prostatectomy? cT3, OR, PSA, RP, RPP
18  2010 Patient risk stratification using Gleason score concordance and upgrading among men with prostate biopsy Gleason score 6 or 7. RP, TRUS
19  2007 A pretreatment table for the prediction of final histopathology after radical prostatectomy in clinical unilateral T3a prostate cancer. PSA, RP
20  2001 The 1989 patterns of care study for prostate cancer: five-year outcomes. bNED, CCC, GI, GU, PCS, RTOG
21  1998 Cribriform carcinoma of the prostate and cribriform prostatic intraepithelial neoplasia: incidence and clinical implications. CC, HGCP, PSA
22  1997 Family history of prostate cancer in patients with localized prostate cancer: an independent predictor of treatment outcome. bRFS, iPSA, RP, RT